Today: 6 April 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Kweichow Moutai stock today: Scam alert puts 600519 in focus before Shanghai open

Kweichow Moutai stock today: Scam alert puts 600519 in focus before Shanghai open

Kweichow Moutai Class A shares closed at 1,376 yuan in Shanghai, down 0.43%, as the company warned of counterfeit links selling Feitian Moutai at 1,499 yuan. The liquor sector rose 0.74%, but major baijiu brands saw price drops, with Feitian Moutai’s wholesale price down 31% since early 2025. Moutai said it has not authorized any “enterprise direct supply” links and may take legal action.
19 January 2026
·
Nestle stock price falls in Zurich on tariff jitters; what investors watch before Feb. 19 results

Nestle stock price falls in Zurich on tariff jitters; what investors watch before Feb. 19 results

Nestle shares fell 0.73% to 74.69 Swiss francs Monday as the Swiss Market Index dropped 1.02% amid broad European losses. The decline followed U.S. tariff threats tied to the Greenland dispute and ongoing fallout from Nestle’s recent infant nutrition recall. The Swiss franc posted its strongest daily gain against the dollar in a month. Nestle’s stock is down about 5.1% for 2026 so far.
19 January 2026
·
PetroChina stock price today: 601857 in focus before Shanghai open as ‘flash boys’ curb meets steady oil

PetroChina stock price today: 601857 in focus before Shanghai open as ‘flash boys’ curb meets steady oil

PetroChina’s A shares closed 0.2% higher at 9.82 yuan in Shanghai Monday, with trading volume at 107.66 million shares. China’s securities regulator ordered brokers to remove client servers from exchange data centers, targeting high-frequency trading. Oil prices held steady, with Brent at $64.14 a barrel. The Shanghai Composite rose 0.29% to 4,114 as overall market turnover fell.
19 January 2026
··
China Construction Bank Corporation Class A stock price in focus ahead of China loan-rate call

China Construction Bank Corporation Class A stock price in focus ahead of China loan-rate call

China Construction Bank’s Shanghai shares slipped 0.1% to 8.94 yuan Monday, ahead of China’s loan prime rate decision expected to hold steady for an eighth month. Other major state banks also fell. New home prices dropped 0.4% in December, deepening property market concerns. Analysts warn weak demand and margin pressure may persist even if rates are cut.
19 January 2026
··
Hermes International stock slides as tariff jitters hit luxury shares — what to watch next

Hermes International stock slides as tariff jitters hit luxury shares — what to watch next

Hermès shares fell 3.52% to 2,113 euros in Paris on Monday as U.S. tariff threats triggered a sell-off in European luxury stocks. The euro zone volatility index hit its highest level since November. Trump announced a 10% tariff on several European countries starting Feb. 1, with a possible increase to 25% in June if no Greenland deal is reached. Hermès will report 2025 results on Feb. 12.
19 January 2026
·
SAP stock drops 3% in Frankfurt as tariff jitters hit tech; Fresenius tie-up and earnings loom

SAP stock drops 3% in Frankfurt as tariff jitters hit tech; Fresenius tie-up and earnings loom

SAP shares fell 3.1% to 195.96 euros in Frankfurt on Monday, hit by a broad tech selloff after U.S. President Trump threatened tariffs on eight European nations. The company announced a digital healthcare partnership with Fresenius, planning a “mid three-digit million euro” investment. SAP’s earnings are due January 29. The STOXX 600 index dropped 1.2%, with tech stocks down 2.9%.
19 January 2026
···
Novo Nordisk stock drops in Copenhagen as Wegovy pill demand gets its first real test

Novo Nordisk stock drops in Copenhagen as Wegovy pill demand gets its first real test

Novo Nordisk B shares fell 2.8% Monday in Copenhagen, closing at 378.15 crowns as investors reacted to early U.S. prescription data for the new oral form of Wegovy. Around 4.7 million shares traded. U.S. prescriptions for oral Wegovy reached nearly 3,100 for the week ending Jan. 9, while overall Wegovy prescriptions dropped 11%. Full-year results are due Feb. 4.
19 January 2026
··
RTX stock at a fresh 52-week high: what to watch before Jan. 27 earnings

RTX stock at a fresh 52-week high: what to watch before Jan. 27 earnings

RTX Corp closed at a new 52-week high of $201.92 Friday, its seventh consecutive gain, after also hitting a fresh intraday peak. U.S. markets were shut Monday for Martin Luther King Jr. Day. Investors await RTX’s fourth-quarter and full-year results on Jan. 27, with attention on guidance and delivery updates. Global risk appetite faded after President Trump revived tariff threats over Greenland.
19 January 2026
··
Wells Fargo stock in focus as Wall Street reopens and Trump’s credit-card rate cap deadline hits

Wells Fargo stock in focus as Wall Street reopens and Trump’s credit-card rate cap deadline hits

Wells Fargo shares closed at $88.38 Friday, down 0.65%, as investors await details on President Trump’s proposal to cap credit card interest rates at 10% starting Jan. 20. U.S. equity futures fell over 1.2% after new tariff threats targeting eight European countries. Wall Street will remain closed Monday for Martin Luther King Jr. Day. Banks say they still lack clarity on how the proposed rate cap would be enforced.
19 January 2026
··
HSBC share price holds near 52-week high as FTSE dips on Trump tariff threat — what to know next

HSBC share price holds near 52-week high as FTSE dips on Trump tariff threat — what to know next

HSBC shares closed up 0.55% at 1,238.8 pence in London, near a 52-week high. The FTSE 100 fell 0.4% after new U.S. tariff threats hit European markets. HSBC confirmed a 6.13% stake in International Personal Finance and set Jan. 23 for a Hong Kong court hearing on Hang Seng Bank’s privatisation. Investors await HSBC’s annual results on Feb. 25.
19 January 2026
····
AstraZeneca share price slips in London as tariff threat rattles markets; EMA review and earnings in focus

AstraZeneca share price slips in London as tariff threat rattles markets; EMA review and earnings in focus

AstraZeneca shares fell 1.15% to 13,890 pence in London as markets reacted to President Trump’s threat of new U.S. tariffs on Britain and other European countries. The FTSE 100 closed down 0.4%. AstraZeneca announced EU validation for Enhertu and a $630 million buyout of China cell-therapy rights. Investors trimmed risk ahead of possible trade retaliation.
19 January 2026
···
Coca-Cola stock price: KO stuck near $70 as tariff jitters hit futures and earnings loom

Coca-Cola stock price: KO stuck near $70 as tariff jitters hit futures and earnings loom

U.S. markets remained closed Monday for Martin Luther King Jr. Day as global stocks and U.S. futures fell on new tariff threats. Coca-Cola shares held steady at $70.44, down 0.1%, with earnings due Feb. 10 and a CEO transition set for March 31. PepsiCo slipped 0.2%, Keurig Dr Pepper dropped 1.8%. Coca-Cola named Sedef Salingan Sahin chief digital officer in a recent filing.
19 January 2026
··
1 … 294 295 296 297 298 … 733

Stock Market Today

  • Alaska Air Faces Challenges with Bearish Q1 EPS Outlook, Investors Weigh Options
    April 6, 2026, 2:40 PM EDT. Alaska Air Group (ALK) revised its first-quarter 2026 earnings outlook downward, expecting an adjusted loss per share between $1.50 and $2.00, hurt by soaring fuel costs, operational disruptions, and severe weather events. Fuel prices, especially from key supplier Singapore, have surged nearly 400% since February, raising economic fuel price expectations to $2.90-$3.00 per gallon. Additional strain comes from unrest in Puerto Vallarta and historic flooding in Hawaii, impacting about 30% of capacity and dampening demand during peak travel. Analysts have downgraded earnings projections for Q1, Q2, and the full year, reflecting diminished broker confidence. ALK's stock has fallen significantly over the past three months, underperforming peers in the airline sector, prompting investors to reconsider holding positions amid ongoing challenges.
Go toTop